Collaboration Details

Print  Close

Title of Collaborative Activity:

FDA-NCI Monthly Meeting

Description of Collaborative Activity:

A monthly meeting to enhance communication between the two agencies, thereby expediting the development of new anti-cancer agents.  General topics discussed include patient safety, clinical efficacy, and regulatory pathways to licensure; as well as an understanding of the operations of the sister agencies.

Type of Collaborative Activity:

Select Type of Collaborative Activity

Year the Collaborative Activity Originated:


NIH Participating Institutes/Centers/Office of the Director:


HHS Agency Collaborators on this Activity: